Curasan Overview

  • Founded
  • 1988
  • Status
  • Private
  • Employees
  • 31
  • Latest Deal Type
  • Buyout/​LBO
  • Investors
  • 2

Curasan General Information


curasan AG is a Germany based company engaged in developing, producing and marketing of biomaterials and medical devices for bone and tissue regeneration. It is focused on biomimetic bone grafting materials for the use in orthopedics, traumatology, spine surgery and dental implantology. The group offers product pipeline for bone and tissue regeneration under the CERASORB brand. Other areas of application in the product range include products for are wound healing and osteoarthritis therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Lindigstraße 4
  • 63801 Kleinostheim
  • Germany
+49 06027 0000000

Curasan Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Curasan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Buyout/LBO 16-Dec-2020 Completed Generating Revenue/Not Profitable
5. Bankruptcy: Admin/Reorg 01-Jun-2020 Completed Bankruptcy: Admin/Reorg
4. PIPE 12-Dec-2017 00.00 000.00 Completed Profitable
3. PIPE 19-Dec-2016 00.000 000.00 Completed Profitable
2. PIPE 28-May-2015 $1.14M $17.3M Completed Profitable
1. IPO 20-Jul-2000 $21.9M $16.2M 000.00 Completed Generating Revenue
To view Curasan’s complete valuation and funding history, request access »

Curasan Patents

Curasan Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9907884-B2 Biodegradable composite material Active 31-May-2011 000000000 00
US-20140170202-A1 Biodegradable composite material Granted 31-May-2011 000000000 00
EP-2714112-A2 Biodegradable composite material Granted 31-May-2011 000000000
EP-2714112-B1 Biodegradable composite material Active 31-May-2011 000000000
JP-2014515966-A Biodegradable composite material Granted 31-May-2011 A61L27/56 0

Curasan Executive Team (6)

Name Title Board Seat Contact Info
Dirk Dembski Chief Executive Officer
Daniel Schiffer Chief Operating Officer
Gregor Siebert Head of Marketing and Sales
You’re viewing 3 of 6 executive team members. Get the full list »

Curasan Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curasan Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Donau Invest Beteiligungs Venture Capital Majority 000 0000 000000 0
New Frontier Health Corporation Minority 000 0000 000000 0
To view Curasan’s complete investors history, request access »

Curasan Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 03-Jul-2019 0000000000 Surgical Devices 0000000 0
0000000 00000 18-Mar-2013 0000000000 Medical Supplies
Pro-Tec Medizinische Produkte 21-Mar-2001 Merger/Acquisition Biotechnology
To view Curasan’s complete acquisitions history, request access »

Curasan Subsidiaries (1)

Company Name Industry Location Founded
00000 Surgical Devices Vienna, Austria 0000
To view Curasan’s complete subsidiaries history, request access »